B. James Tananbaum

Affiliations

  • Large Shareholder, Director at Alumis Inc. (ALMS), 2024-07-04
  • at Kinnate Biopharma Inc. (KNTE), 2024-04-05
  • President And Ceo at Pardes Biosciences Inc. (PRDS), 2023-08-31
  • Large Shareholder at Theseus Pharmaceuticals Inc. (THRX), 2023-07-19
  • Large Shareholder at Aclaris Therapeutics Inc. (ACRS), 2021-11-03
  • Large Shareholder, Director at Gemini Therapeutics Inc. (GMTX), 2021-10-06
  • Director at Quantum-Si Inc (QSI), 2021-06-14
  • Large Shareholder at 10X Genomics Inc. (TXG), 2020-05-14
  • Large Shareholder at Aerie Pharmaceuticals Inc (AERI), 2020-03-02
  • Large Shareholder at Aimmune Therapeutics Inc. (AIMT), 2016-08-19
  • Large Shareholder at Intellia Therapeutics Inc. (NTLA), 2016-05-05
  • Large Shareholder at Ambit Biosciences Corp (AMBI), 2013-10-16
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
ALMS $16.00 2,187,500 Large Shareholder, Director 4,202,670 2024-07-01 Filing
ALMS $16.00 312,500 Large Shareholder, Director 5,584,889 2024-07-01 Filing
KNTE $2.80 229,044 Large Shareholder, Director 520,711 2023-05-08 Filing
KNTE $2.80 1,550,956 Large Shareholder, Director 3,525,957 2023-05-08 Filing
PRDS $10.00 325,000 Large Shareholder, Director 325,000 2021-12-22 Filing